Table 1. Patient characteristics.
Characteristics | Proven/Probable CNS IA*(n = 8) | Possible/CNS IA*(n = 22) | No CNS IA (n = 25) | |
Age (median, range) | 38 (4–82) | 42 (8–68) | 55 (0–73) | |
Gender (female/male) | 4/4 | 11/11 | 14/11 | |
Underlying disease | ||||
AML | 1 | 8 | 3 | |
ALL | 4 | 4 | 7 | |
NHL | 2 | 4 | 10 | |
AIHA | 0 | 0 | 1 | |
MPN | 0 | 1 | 0 | |
MDS | 0 | 1 | 0 | |
Aplastic Anemia | 0 | 1 | 0 | |
CVID | 0 | 1 | 0 | |
Solid Tumor | 0 | 0 | 1 | |
Other | 1 | 2 | 3 | |
Among them patients after/with | ||||
Allo-HSCT | 3 | 9 | 2 | |
Auto-HSCT | 0 | 1 | 0 | |
HIV infection | 0 | 1 | 0 |
according to 2008 EORTC/MSG Criteria modified by Schwartz et al.
AML: acute myeloid leukemia; ALL acute lymphoblastic leukemia; NHL Non-Hodgkińs-Lymphoma; MDS: Myelodysplastic Syndrome; MPN: myeloproliferative neoplasia; Allo-HSCT: allogeneic hematopoietic stem cell transplantation; Auto-HSCT: autologous hematopoietic stem cell transplantation; AIHA: Autoimmunehemolytic anemia; CVID : common variable immunodeficiency syndrome; other: Primary chronic polyarthritis, HIV infection, sarcoidosis, miliary tuberculosis, bacterial meningitis.